Dimensional Fund Advisors’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-569,372
Closed -$4.09M 3290
2025
Q2
$4.09M Sell
569,372
-7,827
-1% -$43.4K ﹤0.01% 2578
2025
Q1
$3.46M Sell
577,199
-166,453
-22% -$1.31M ﹤0.01% 2601
2024
Q4
$5.8M Sell
743,652
-48,771
-6% -$486K ﹤0.01% 2493
2024
Q3
$8.56M Sell
792,423
-137,874
-15% -$1.34M ﹤0.01% 2365
2024
Q2
$7.84M Sell
930,297
-463,901
-33% -$3.52M ﹤0.01% 2351
2024
Q1
$9.37M Sell
1,394,198
-242,636
-15% -$1.5M ﹤0.01% 2332
2023
Q4
$9.62M Buy
1,636,834
+57,143
+4% +$438K ﹤0.01% 2336
2023
Q3
$15.4M Buy
1,579,691
+462,345
+41% +$5.48M 0.01% 2059
2023
Q2
$13.2M Buy
1,117,346
+288,384
+35% +$3.31M ﹤0.01% 2132
2023
Q1
$8.94M Buy
828,962
+362,943
+78% +$4.64M ﹤0.01% 2279
2022
Q4
$5.39K Buy
466,019
+394,009
+547% +$4.88M ﹤0.01% 2424
2022
Q3
$1.07M Sell
72,010
-1,459
-2% -$20K ﹤0.01% 2861
2022
Q2
$662K Buy
73,469
+2,046
+3% +$14K ﹤0.01% 3004
2022
Q1
$535K Buy
71,423
+28,422
+66% +$198K ﹤0.01% 3134
2021
Q4
$369K Buy
+43,001
New +$374K ﹤0.01% 3231
2020
Q4
Sell
-5,964
Closed -$56K 3349
2020
Q3
$56K Buy
+5,964
New +$62.2K ﹤0.01% 3301

Other funds holding COGT

Dimensional Fund Advisors's COGT Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 569,372 shares — an estimated $4.09M sold.

Dimensional Fund Advisors first reported a position in COGT in Q3 2020 and held it in 16 quarters. The position peaked at $15.4M in Q3 2023. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 569,372 Cogent Biosciences shares in Q3 2025, an estimated $4.09M.
  • Dimensional Fund Advisors first reported a position in Cogent Biosciences in Q3 2020 and held it in 16 quarters.
  • Dimensional Fund Advisors's Cogent Biosciences position peaked at $15.4M in Q3 2023.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.